Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 13,145	$ 91,407
Prepaid expenses	82,107	208,056
Total Current Assets	95,252	299,463
Marketable securities held in Trust Account	231,293,983	230,021,238
TOTAL ASSETS	231,389,235	230,320,701
Current liabilities:
Accrued expenses	3,209,442	312,942
Advances from related parties	3,370	870
Promissory note – related party	304,980
Total Current Liabilities	3,517,792	313,812
Warrant liabilities	1,047,418	18,505,400
Deferred underwriting commission payable	8,650,000	8,650,000
Total Liabilities	13,215,210	27,469,212
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of approximately $10.06 at September 30, 2022 and of approximately $10.00 at December 31, 2021	231,293,983	230,021,238
Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding at September 30, 2022 and December 31, 2021
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding, at September 30, 2022 and December 31, 2021	575	575
Additional paid-in capital
Accumulated deficit	(13,120,533)	(27,170,324)
Total Shareholders’ Deficit	(13,119,958)	(27,169,749)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 231,389,235	$ 230,320,701